How would you define treatment-resistance?
Like I am on two APs (Abilify plus Amisulpride), but a responder to this combination and mostly have no symptoms.
In this case, might Evenamide work for me? I mean I am not treatment resistant, but responsd adequately to the current combination. However, I have side effects, and to change Amisulpride with Evenamide which seems to have no serious side effects seems to be the logical choice.
I guess, what I mean is that they are testing on a very specific subset of people, who are classified as treatment resistant. But, how exactly are they defining treatment-resistance? Like, would I qualify as a potential responder to Evenamide, would you know?